enit

Contattaci Contact Us

Home>Eventi>International Symposium On New Biological Insights And Novel Drugs In Acute Leukemia
Video & Slide

12 ottobre 2021 - Giorno 1

  • Introduction

    Relatore Francesco Lanza

    Data Intervento 12/10/2021 - 08:30

  • Genetic landscape of AML and its relevance for treatment

    Relatore Brunangelo Falini

    Data Intervento 12/10/2021 - 08:40

  • DNA repair inhibitors: a possible role in myeloid malignancies

    Relatore Damiano Rondelli

    Data Intervento 12/10/2021 - 09:00

  • Mechanism of resistance

    Relatore Giovanni Martinelli

    Data Intervento 12/10/2021 - 09:20

  • General Discussion Session I

    Relatore -

    Data Intervento 12/10/2021 - 09:40

  • Secondary AML

    Relatore Arnon Nagler

    Data Intervento 12/10/2021 - 10:20

  • Induction and Consolidation Therapy of high risk Leukemia

    Relatore Felicetto Ferrara

    Data Intervento 12/10/2021 - 10:40

  • Allogeneic SCT for High Risk leukemia: when and how

    Relatore Emanuele Angelucci

    Data Intervento 12/10/2021 - 11:00

  • General Discussion Session II

    Relatore -

    Data Intervento 12/10/2021 - 11:20

  • Targeting Apoptosis in AML - venetoclax

    Relatore Dietger Niederwisier

    Data Intervento 12/10/2021 - 13:00

  • Midostaurine and new FLT3 inhibitors

    Relatore Giovanni Marconi

    Data Intervento 12/10/2021 - 13:20

  • IDH1 and IDH2 inhibitors

    Relatore Jorge Cortés

    Data Intervento 12/10/2021 - 13:40

  • Car-T

    Relatore Bipin Savani

    Data Intervento 12/10/2021 - 14:00

  • Strategy to overcome resistance of emerging agents

    Relatore Tapan M. Kadia

    Data Intervento 12/10/2021 - 14:20

  • Targeting MDM2 as a new treatment approach in AML

    Relatore Tapan M. Kadia

    Data Intervento 12/10/2021 - 15:00

  • Bispecific antibody construct for the treatment of AML

    Relatore Marion Subklewe

    Data Intervento 12/10/2021 - 15:40

  • Hedgehog inhibitors

    Relatore Adriano Venditti

    Data Intervento 12/10/2021 - 16:00

  • Immune based approaches in AML

    Relatore Naval Daver

    Data Intervento 12/10/2021 - 16:20

  • General Discussion Session IV

    Relatore -

    Data Intervento 12/10/2021 - 16:40

  • Clinical impact of MRD monitoring

    Relatore Nigel Russell

    Data Intervento 12/10/2021 - 17:20

  • Flow cytometry monitoring

    Relatore Francesco Buccisano

    Data Intervento 12/10/2021 - 17:40

  • MRD by NGS

    Relatore Peter J. M. Valk

    Data Intervento 12/10/2021 - 18:00

  • General Discussion Session V

    Relatore -

    Data Intervento 12/10/2021 - 18:40

13 ottobre 2021 - Giorno 2

  • Mast cell leukemia

    Relatore Michela Rondoni

    Data Intervento 13/10/2021 - 09:00

  • Blastic plasmacytoid dendritic cell neoplasm (BPDCN)

    Relatore Livio Pagano

    Data Intervento 13/10/2021 - 09:20

  • General Discussion Session VI

    Relatore -

    Data Intervento 13/10/2021 - 09:40

  • High-end GENome-editing platform to deliver next generation allogeneic iPSC-derived CAR-NK and T immunotherapy “GENiCAR”

    Relatore Alejandro Madrigal

    Data Intervento 13/10/2021 - 10:00

  • Intersecting genomic medicine and system pharmacology for profiling therapeutic sensitivity in leukemia

    Relatore Giovanni Roti

    Data Intervento 13/10/2021 - 10:20

  • Haploidentical transplantation in AML

    Relatore Marcos J. De Lima

    Data Intervento 13/10/2021 - 10:40

  • General Discussion Session VII

    Relatore -

    Data Intervento 13/10/2021 - 11:00

  • Ph+ leukemia: biology and resistance

    Relatore Simona Soverini

    Data Intervento 13/10/2021 - 11:40

  • Treatment of Ph+ALL in young and elderly

    Relatore Alessandro Rambaldi

    Data Intervento 13/10/2021 - 12:00

  • Transplant in Ph+

    Relatore Sebastian Giebel

    Data Intervento 13/10/2021 - 12:20

  • General Discussion Session VIII

    Relatore -

    Data Intervento 13/10/2021 - 12:40

  • Transplant in Ph-

    Relatore Alexandros Spdyridonidis

    Data Intervento 13/10/2021 - 14:00

  • First line therapy and overall approach

    Relatore Elias J. Jabbour

    Data Intervento 13/10/2021 - 14:20

  • Role of immunotherapy in refractory-resistant ALL

    Relatore Francesco Lanza

    Data Intervento 13/10/2021 - 14:40

  • Ph Like leukemia

    Relatore Ilaria Iacobucci

    Data Intervento 13/10/2021 - 15:00

  • General Discussion Session IX

    Relatore -

    Data Intervento 13/10/2021 - 15:20

  • Conclusion of the Symposium

    Relatore Francesco Lanza

    Data Intervento 13/10/2021 - 15:40

Area riservata

Login Annulla
 

APP FONDAZIONE MENARINI

SCOPRI L'APP


Pills of Art Menarini

“Menarini Pills of Art”
Il nuovo progetto multimediale di Menarini legato al mondo dell’arte

VISITA IL SITO


Nuovi Progetti: MINUTI DIGITALE

VISITA IL SITO


Minuti Menarini Online

Abbonati gratis alla rivista cartacea

ABBONATI GRATUITAMENTE


Fondazione Menarini



ISCRIVITI ALLA NEWSLETTER

Ricevi ogni mese le informazioni sulle attività della Fondazione Menarini.

Iscriviti

VGFM DATA-LAYER

Fondazione Menarini
Fondazione Menarini, Centro Direzionale Milanofiori 20089 Rozzano (MI) - Edificio L - Strada 6
Tel. +39 02 55308110 Fax +39 02 55305739 C.F. 94265730484